PPARγ-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNFα secretion is not mediated by PTEN regulation
- 11 April 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 303 (3), 782-787
- https://doi.org/10.1016/s0006-291x(03)00418-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The peroxisome proliferator‐activated receptor α regulates amino acid metabolismThe FASEB Journal, 2001
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000
- Roles of PPARs in health and diseaseNature, 2000
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors α and γMolecular and Cellular Endocrinology, 1998
- Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM PatientsDiabetes, 1997
- Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and AntagonistsJournal of Biological Chemistry, 1997
- Novel Sequence Determinants in Peroxisome Proliferator SignalingJournal of Biological Chemistry, 1995
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995
- Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptorsNature, 1992